At Mallinckrodt, we use strategic vision and employee-driven momentum to pursue a powerful mission: Listening for needs and delivering solutions. As a leader in specialty pharmaceuticals, we develop, manufacture, market and distribute innovative treatments for underserved patient populations within neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal products. . Our expertise also extends into acute and critical care hospital products, as well as our broad portfolio of generic prescription medicines and active pharmaceutical ingredients. Together, we’re helping shape the future of the specialty pharmaceuticals industry by leveraging the values our founders instilled over 155 years ago – quality, integrity and service. To learn more about Mallinckrodt, visit www.mallinckrodt.com. Equal Opportunity Employer Mallinckrodt Pharmaceuticals provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, gender identity, national origin, age, disability, veteran status or genetics. In addition to federal law requirements, Mallinckrodt Pharmaceuticals complies with applicable state and local laws governing nondiscrimination in employment in every location in which the company has facilities. This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation and training.
View Top Employees from Mallinckrodt PharmaceuticalsWebsite | http://www.mnk.com |
Ticker | MNK |
Revenue | $3.16 billion |
Funding | $45 million |
Employees | 3,346 (2,930 on RocketReach) |
Founded | 1867 |
Address | College Business & Technology Park Cruiserath Blanchardstown, Dublin, Leinster D15, IE |
Phone | +44 1784 636700 |
Fax | (314) 654-5381 |
Technologies |
JavaScript,
HTML,
PHP
+202 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Biotechnology, Specialty Pharmaceuticals, Healthcare, Science and Engineering, Nuclear Imaging Products, Active Pharmaceutical Ingredients, Specialty Generics, Pain Medications, Intrathecal, Autoimmune and Rare Diseases, Neonatal Respiratory Critical Care, Hemostasis Products, Central Nervous System Drugs |
Keywords | Specialty Pharmaceutical |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Mallinckrodt Pharmaceuticals employee's phone or email?
The Mallinckrodt Pharmaceuticals annual revenue was $3.16 billion in 2024.
Alexander Hladky is the Vice President, Global Procurement of Mallinckrodt Pharmaceuticals.
2,930 people are employed at Mallinckrodt Pharmaceuticals.
Mallinckrodt Pharmaceuticals is based in Dublin, Leinster.
The NAICS codes for Mallinckrodt Pharmaceuticals are [325, 32, 32541, 3254].
The SIC codes for Mallinckrodt Pharmaceuticals are [283, 28].